CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
Shih-Chieh ChangYi-Chun LaiYen-Chung ChenNai-Kuan WangWei-Shu WangJiun-I LaiPublished in: Asia-Pacific journal of clinical oncology (2017)
We report a significant upregulation of CBX3/HP1-gamma in NSCLC patients, and also a possible relationship between CBX3/HP1-gamma expression and EGFR mutation.
Keyphrases
- small cell lung cancer
- poor prognosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cell proliferation
- epidermal growth factor receptor
- binding protein
- signaling pathway
- advanced non small cell lung cancer
- patient reported outcomes
- long non coding rna
- amino acid
- brain metastases